These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 20609855)
21. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex. Lustgarten J; Waks T; Eshhar Z Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555 [TBL] [Abstract][Full Text] [Related]
22. Carrier-independent hapten recognition and promiscuous MHC restriction by CD4 T cells induced by trinitrophenylated peptides. Kohler J; Hartmann U; Grimm R; Pflugfelder U; Weltzien HU J Immunol; 1997 Jan; 158(2):591-7. PubMed ID: 8992972 [TBL] [Abstract][Full Text] [Related]
23. T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy. Noy R; Eppel M; Haus-Cohen M; Klechevsky E; Mekler O; Michaeli Y; Denkberg G; Reiter Y Expert Rev Anticancer Ther; 2005 Jun; 5(3):523-36. PubMed ID: 16250828 [TBL] [Abstract][Full Text] [Related]
24. Delayed drug hypersensitivity: models of T-cell stimulation. Adam J; Pichler WJ; Yerly D Br J Clin Pharmacol; 2011 May; 71(5):701-7. PubMed ID: 21480949 [TBL] [Abstract][Full Text] [Related]
25. Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy. Padovan E; Bauer T; Tongio MM; Kalbacher H; Weltzien HU Eur J Immunol; 1997 Jun; 27(6):1303-7. PubMed ID: 9209477 [TBL] [Abstract][Full Text] [Related]
26. Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands. Chen Y; Shi Y; Cheng H; An YQ; Gao GF IUBMB Life; 2009 Jun; 61(6):579-90. PubMed ID: 19472182 [TBL] [Abstract][Full Text] [Related]
27. Approach to the patient with drug allergy. Schnyder B Med Clin North Am; 2010 Jul; 94(4):665-79, xv. PubMed ID: 20609856 [TBL] [Abstract][Full Text] [Related]
28. Cross-reactive trinitrophenylated peptides as antigens for class II major histocompatibility complex-restricted T cells and inducers of contact sensitivity in mice. Limited T cell receptor repertoire. Kohler J; Martin S; Pflugfelder U; Ruh H; Vollmer J; Weltzien HU Eur J Immunol; 1995 Jan; 25(1):92-101. PubMed ID: 7843258 [TBL] [Abstract][Full Text] [Related]
29. HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes. Zanni MP; von Greyerz S; Schnyder B; Brander KA; Frutig K; Hari Y; Valitutti S; Pichler WJ J Clin Invest; 1998 Oct; 102(8):1591-8. PubMed ID: 9788973 [TBL] [Abstract][Full Text] [Related]
30. Danger signs in drug hypersensitivity. Scherer K; Bircher AJ Med Clin North Am; 2010 Jul; 94(4):681-9, xv-x. PubMed ID: 20609857 [TBL] [Abstract][Full Text] [Related]
31. Role of dendritic cells in drug allergy. Blázquez AB; Cuesta J; Mayorga C Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):279-84. PubMed ID: 21659861 [TBL] [Abstract][Full Text] [Related]
35. The role of CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact dermatitis. Saint-Mezard P; Berard F; Dubois B; Kaiserlian D; Nicolas JF Eur J Dermatol; 2004; 14(3):131-8. PubMed ID: 15246935 [TBL] [Abstract][Full Text] [Related]
36. Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene. Bour H; Peyron E; Gaucherand M; Garrigue JL; Desvignes C; Kaiserlian D; Revillard JP; Nicolas JF Eur J Immunol; 1995 Nov; 25(11):3006-10. PubMed ID: 7489735 [TBL] [Abstract][Full Text] [Related]
37. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Pichler WJ; Tilch J Allergy; 2004 Aug; 59(8):809-20. PubMed ID: 15230812 [TBL] [Abstract][Full Text] [Related]
39. Drug hypersensitivity: flare-up reactions, cross-reactivity and multiple drug hypersensitivity. Pichler WJ; Daubner B; Kawabata T J Dermatol; 2011 Mar; 38(3):216-21. PubMed ID: 21342222 [TBL] [Abstract][Full Text] [Related]
40. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function. Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]